Clinical trials
Active, not recruiting Fatty Liver trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seoul National University Hospital | 2 |
| AstraZeneca | 1 |
| Faculty Hospital Kralovske Vinohrady | 1 |
| First Affiliated Hospital of Chongqing Medical University | 1 |
| Genentech, Inc. | 1 |
| General University Hospital, Prague | 1 |
| Göteborg University | 1 |
| Jong Keon Jang | 1 |
| Natalie Torok | 1 |
| Renmin Hospital of Wuhan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fatty Liver | 16 |
| Non-alcoholic Fatty Liver Disease | 8 |
| Liver Cirrhosis | 4 |
| Diabetes Mellitus | 3 |
| Fibrosis | 2 |
| Liver Diseases | 2 |
| Obesity | 2 |
| Overweight | 2 |
| Carcinoma, Hepatocellular | 1 |
| Diabetes Mellitus, Type 2 | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.